Paris-based AI-based medical imanging specialist AZmed SA has secured a €15min Series A financing led by Maison Worms, Techstars, and Tempact Ventures.
https://european-biotechnology.com/wp-content/uploads/2024/04/AZMed.png6541020Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-02-14 08:31:442024-07-08 11:35:36AZmed closes €15m Series A financing